Update on Animal Models of Alpha-Synucleinopathy for Use in Therapeutic Drug Development

Time: 9:30 am
day: Day Two


  • Investigating neuroinflammation with a focus on alpha-synuclein specific T cell responses
  • Exploring preformed fibrils such as motor and non-motor models
  • Deep Divining into AAV-alpha synuclein in rodent and non-human primate models and exploring motor and non-motor endpoints